Document detail
ID

doi:10.1007/s00401-024-02728-8...

Author
Woodworth, Davis C. Nguyen, Katelynn M. Sordo, Lorena Scambray, Kiana A. Head, Elizabeth Kawas, Claudia H. Corrada, María M. Nelson, Peter T. Sajjadi, S. Ahmad
Langue
en
Editor

Springer

Category

Medicine & Public Health

Year

2024

listing date

6/26/2024

Keywords
tdp-43 limbic predominant age-related tdp... frontotemporal lobar degeneration amyotrophic lateral sclerosis hippocampal sclerosis of aging dementia alzheimer’s disease national alzheimer’s coordinating ... alzheimer’s ftld-tdp atrophy available neuropathologic odds pathology tdp-43 data als/ftld-tdp late-nc participants
Metrics

Abstract

TDP-43 proteinopathy is a salient neuropathologic feature in a subset of frontotemporal lobar degeneration (FTLD-TDP), in amyotrophic lateral sclerosis (ALS-TDP), and in limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC), and is associated with hippocampal sclerosis of aging (HS-A).

We examined TDP-43-related pathology data in the National Alzheimer’s Coordinating Center (NACC) in two parts: (I) availability of assessments, and (II) associations with clinical diagnoses and other neuropathologies in those with all TDP-43 measures available.

Part I: Of 4326 participants with neuropathology data collected using forms that included TDP-43 assessments, data availability was highest for HS-A (97%) and ALS (94%), followed by FTLD-TDP (83%).

Regional TDP-43 pathologic assessment was available for 77% of participants, with hippocampus the most common region.

Availability for the TDP-43-related measures increased over time, and was higher in centers with high proportions of participants with clinical FTLD.

Part II: In 2142 participants with all TDP-43-related assessments available, 27% of participants had LATE-NC, whereas ALS-TDP or FTLD-TDP (ALS/FTLD-TDP) was present in 9% of participants, and 2% of participants had TDP-43 related to other pathologies (“Other TDP-43”).

HS-A was present in 14% of participants, of whom 55% had LATE-NC, 20% ASL/FTLD-TDP, 3% Other TDP-43, and 23% no TDP-43.

LATE-NC, ALS/FTLD-TDP, and Other TDP-43, were each associated with higher odds of dementia, HS-A, and hippocampal atrophy, compared to those without TDP-43 pathology.

LATE-NC was associated with higher odds for Alzheimer’s disease (AD) clinical diagnosis, AD neuropathologic change (ADNC), Lewy bodies, arteriolosclerosis, and cortical atrophy.

ALS/FTLD-TDP was associated with higher odds of clinical diagnoses of primary progressive aphasia and behavioral-variant frontotemporal dementia, and cortical/frontotemporal lobar atrophy.

When using NACC data for TDP-43-related analyses, researchers should carefully consider the incomplete availability of the different regional TDP-43 assessments, the high frequency of participants with ALS/FTLD-TDP, and the presence of other forms of TDP-43 pathology.

Woodworth, Davis C.,Nguyen, Katelynn M.,Sordo, Lorena,Scambray, Kiana A.,Head, Elizabeth,Kawas, Claudia H.,Corrada, María M.,Nelson, Peter T.,Sajjadi, S. Ahmad, 2024, Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database, Springer

Document

Open

Share

Source

Articles recommended by ES/IODE AI